Showing results (21-30 of 220) with videos related to

Sort By:
Pageof 22
World Journal of Urology|August 31, 2012
Urinary BTA: indicator of bladder cancer or of hematuriaMakito Miyake, Steve Goodison, Wasia Rizwani, et al.
Journal of Hematology & Oncology|September 6, 2013
Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditionsMakito Miyake, Steve Goodison, Adrienne Lawton, et al.
BMC Urology|August 30, 2012
Influencing factors on the NMP-22 urine assay: an experimental modelMakito Miyake, Steve Goodison, Evan Gomes Giacoia, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Influencing Factors on the Oncuria™ Urinalysis Assay: An Experimental ModelKaoru Murakami, Ian Pagano, Runpu Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2014
Urinary protein biomarker panel for the detection of recurrent bladder cancerCharles J Rosser, Myron Chang, Yunfeng Dai, et al.
BMC Urology|May 8, 2012
IL-8 as a urinary biomarker for the detection of bladder cancerVirginia Urquidi, Myron Chang, Yunfeng Dai, et al.
Oncotarget|May 28, 2016
Urinary mRNA biomarker panel for the detection of urothelial carcinomaVirginia Urquidi, Mandy Netherton, Evan Gomes-Giacoia, et al.
BMC Cancer|February 15, 2014
Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancerMakito Miyake, Adrienne Lawton, Yunfeng Dai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 8, 2016
A Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder CancerSijia Huang, Lei Kou, Hideki Furuya, et al.
Pageof 22